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a b s t r a c t
The vasoconstrictor neuropeptide Y (NPY) has been shown to down-regulate tyrosine
hydroxylase expression in cultured adrenal chromaffin cells, which probably accounts
for the higher plasma resting norepinephrine (NE) and epinephrine (E) concentrations
observed in Y1 knock-out mice (Y1/) than in wild-type mice (Y1+/+). The aim of this
work was to study the hemodynamic response of Y1/mice to an acute stimulation of the
sympathetic nervous system (cold pressor test, CPT). Plasma catecholamine concentrations
were higher in Y1/mice than inwild-type animals at the end of the CPT. The CPT-induced
increase in mean arterial blood pressure (MAP) and heart rate (HR) was similar in both
genotypes. Independently of the genotype, females had significantly slower HR than males
throughout the 15 min duration of the CPT. There was no difference in the sensitivity of the
baroreceptor reflex, as reflected by the change in HR divided by the concurrent change in
MBP between Y1/ and Y1+/+ mice. In conclusion, mice lacking the Y1 receptor can
maintain normal hemodynamic response to an acute activation of the sympathetic system,
albeit at the expense of increased catecholamine discharge.
# 2006 Elsevier Inc. All rights reserved.
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Neuropeptide Y (NPY) is a 36-amino acid peptide co-released
with norepinephrine (NE) during sympathetic nerve activa-
tion. NPY stimulates different G-protein coupled receptors
termed Y1, Y2, Y3, Y4 and Y5 [8,10]. NPY is an important
modulator of sympathetic function, as it potentiates adrener-
gic vasoconstrictor activity by stimulating the Y1 receptor [3].
In the heart and blood vessels of a variety of animals, NPY
exerts pre-junctional inhibitory effects on NE release from* Corresponding author. Tel.: +41 21 3140741; fax: +41 21 3140761.
E-mail address: Eric.Grouzmann@chuv.ch (E. Grouzmann).
Abbreviations: NPY, neuropeptide Y; NE, norepinephrine; E, epinep
pressor test; HR, heart rate; MAP, arterial blood pressure; TH, tyrosin
0196-9781/$ – see front matter # 2006 Elsevier Inc. All rights reserved
doi:10.1016/j.peptides.2006.11.022sympathetic nerve endings by activating the Y2 receptor [12].
In addition, as observed in mice, parasympathetic nerve
terminals in the heart possess Y2 receptors which, when
activated, reduce acetylcholine release [11]. We have shown
that Y1 knock-out mice (Y1/) lose their ability to potentiate
NE-induced vasoconstriction, but still have a normal blood
pressure, suggesting a minor role of NPY in the maintenance
of blood pressure regulation [9].
Recently, the role of NPY in cardiac sympathovagal
balance was investigated in mice lacking the Y1 receptor. Ahrine; Y1/, Y1 knock-out mice; Y1+/+, wild-type mice; CPT, cold
e hydroxylase
.
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compatible with a reduced sympathetic and/or an increased
parasympathetic nerve activity [2]. We have recently shown
that NPY triggers the release of catecholamines in primary
cultures of mice adrenal chromaffin cells, and that this
effect is abolished in corresponding cells isolated from
adrenal glands of Y1/ animals [1]. Compared to Y1+/+
mice, both the adrenal content and the constitutive release
of catecholamines were increased in chromaffin cells from
Y1/mice. The high turnover of adrenal catecholamines in
Y1/ mice was associated with an enhancement of
tyrosine hydroxylase (TH) activity and expression. In resting
animals, plasma catecholamine concentrations were higher
in Y1/ mice compared to wild-type mice. This is
compatible with a role of NPY in controlling the release
and the synthesis of catecholamines from the adrenal
medulla [1].
The implication of the Y1 receptor in the hemodynamic
response to an acute sympathetic stimulationhas not yet been
studied in mice. This urged us to compare the blood pressure
and heart rate response to a cold pressor test (CPT) in Y1+/+
and Y1/ mice.2. Material and methods
2.1. Animals
We used 3-month-old male and female mice lacking the NPY
Y1 receptor [9] and their corresponding wild-type homologues
(C57BL/6). They were backcrossed for eight generations on a
C57BL/6 background (IFFA Credo, L’Arbresle, France) by
crossing heterozygous Y1/+ with C57BL/6 wild-type mice.
Heterozygous mice were then crossed together in order to
produce homozygous mutants (Y1/) and wild-type control
littermates (Y1+/+).
2.2. Catecholamine determination in mice plasma
The mice were anesthetized with halothane and under-
went catheterization of the right carotid artery for blood
sampling, heart rate and blood pressure monitoring as
described below. They were allowed to recover from
anaesthesia for 4 h. Blood was collected through the arterial
line (0.2 ml/sample) and centrifuged immediately at 2000 g
as previously described [4]. This method of sampling is
minimally stressful and appropriate to measure plasma
catecholamine in mice [4]. Plasma was separated and frozen
at 80 8C until assayed. NE and E in plasma were extracted
on alumina and measured by HPLC with electrochemical
detection [5].
2.3. Cold pressor test
Cold pressor test was performed by placing mice in custom-
made Plexiglas tubes partially immersed into ice-cold water
for 15 min. In these mice, blood was collected through the
arterial line 15 min before the CPT, and again 30 s after the end
of the experiment. Simultaneously, blood pressure and heart
rate were measured as described below.2.4. Blood pressure and heart rate
The right common carotid artery was exposed through a
cervical incision and isolated by blunt dissection. A catheter,
formed by a length of PE-10 tubing,was filledwith a solution of
glucose (5%) and heparin (300 IU/ml) and inserted into the
vessel. Xylocaine solution (1%) was used to prevent spasm.
Then, a ligature was tied around the artery, and the catheter
was tunnelled subcutaneously to exit at the back of the neck.
Mice were allowed to recover from the anaesthesia for 4 h and
then were placed in Plexiglas tubes to partially restrict their
movements. Thirty minutes later, the arterial line was
connected to a pressure transducer, and blood pressure
(MAP) and heart rate (HR) were recorded starting 2 min before
the test (B = baseline) and each min along the 15 min duration
of the test. This was done using a computerized data-
acquisition system (Hewlett-Packard scanner, model
HP3852A). Systolic, diastolic, and mean intra-arterial pres-
sures as well as HR were measured simultaneously. Data
represent the average of recordings obtained immediately
before the onset of the test (3 min period) minute per minute
during the 5 min after starting the test, and at the end of the
CPT (t 15 min) [13]. The baroreflex sensitivity was determined
based on the ratio of HR under MAP at each time point along
the duration of the test.
2.5. Statistical analysis
The resultswere analysed by two-waymultivariate analysis of
variance for repeated measurements using the STATA soft-
ware, Version 8.2 (StataCorp LP, 4905 Lakeway Drive, College
Station, TX 77845, USA). The effects of sex, Y1 genotype and
their interaction on the global hormone, BP and HR response
profiles were assessed at the significance level of p < 0.05.3. Results
3.1. Plasma catecholamine concentrations
Baseline plasma NE and E concentrations were increased in
Y1/ compared to wild-type mice both in males and females
(n = 9), (p < 0.05) Fig. 1. Plasma NE was 4.3  0.9 nM in Y1/
males, 3.3  0.3 nM in Y1/ females, 2.8  0.4 nM in Y1+/+
males and 2.8  0.7 nM in Y1+/+ females. Plasma E was
1.1  0.2 and 1.4  0.6 nM in Y1/ males and females,
respectively, and 0.6  0.1 and 0.8  0.5 nM in Y1+/+ males
and females, respectively. There was no difference between
males and females with regard to NE and E plasma
concentrations ([1] and Fig. 1).
At the end of the CPT, catecholamine concentrations raised
to a larger extent in Y1/ than in Y1+/+ mice, both in males
and females (p < 0.01). Plasma NE averaged 23.8  7.9 nM in
Y1/males and 12.9  2.3 nM in Y1/ females compared to
6.3  1.6 nM in Y1+/+ males and 7.2  1.6 nM in Y1+/+ females.
Plasma E was markedly higher in Y1/mice (9.1  1.4 nM in
males and 15.0  4.1 nM in females) compared to Y1+/+ mice
(4.6  1.5 nM inmale and 7.8  1.3 nM in female). At the end of
the CPT, plasma E was higher in Y1/ females than in Y1/
males mice ( p < 0.05).
Fig. 1 – Plasma catecholamine concentrations in Y1S/Smice
and wild-type mice (Y1+/+), before and after CPT. (A) NE
concentration and (B) E concentration; CPT caused a higher
increase of catecholamine plasma levels in Y1S/Smice
than in the wild-type animals. Plasma catecholamine was
measured before and after a CPT in 7 or 8 mice of each
gender and each genotype. *p < 0.05, **p < 0.01 compared to
Y1+/+ mice;
#p < 0.05 compared to Y1S/Smales.
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(HR)
3.2.1. MAP
Basal MAP values were similar in the four groups of resting
animals (Y1/ andY1+/+mice,males or females; Fig. 2A). CPT
induced a rapid and similar increase of MAP in the males and
females of both genotypes. One and 2 min after the beginning
of the test, an increase in MAP was observed, reaching a
maximum at 2 min to decrease at pre-test levels at the end of
the CPT (15 min).
3.2.2. HR
At baseline, wild-type males had significantly higher HR
values than corresponding females (p < 0.05), whereas nosuch a difference was found in Y1/ animals (Fig. 2B). Males
reached occasionally significantly higher HR than females
during the CPT. At the end of CPT (15 min), in all study groups,
HR was significantly lower than at baseline, regardless of the
genotype.
3.2.3. Baroreceptor reflex sensitivity
The analysis of the ratio between the changes in HR and then
in MAP at all the recorded time points did not reveal
differences between Y1/ and Y1+/+ mice (p = 0.19) (data
not shown). The sensitivity of the baroreflex calculated during
the maximal decrease (or increase) MAP or HR, was similar in
all the study groups ( p = 0.87) (data not shown).4. Discussion
This study shows that plasma catecholamine concentrations
increase markedly in response to a CPT in Y1/ compared to
Y1+/+ mice, whereas MAP and HR behave similarly regardless
to the genotype. CPT is a potent stimulus of sympathetic nerve
activity, which manifests by increased catecholamine levels,
transient blood pressure rise, and heart rate acceleration. This
may appear surprising since BIBP3226, a Y1 antagonist has
been shown to blunt CPT-induced pressor effects in rats [7,14].
In our study, the CPT-induced MAP increase was preserved in
the Y1/ mice, which could be explained by an increased
synthesis and release of catecholamines to compensate for
the lack of Y1 stimulation by NPY.
The adrenergic response to CPT is mainly pain- and
partially temperature-mediated [7]. However, E and NE
released by the adrenal medulla reach target organs via the
circulation, whereas NE originating from sympathetic nerve
endings produces its effects locally; it is only afterwards that
the amine overflows from the synaptic cleft into the circula-
tion [6]. Differences were observed between males and
females with regard to plasma NE and E concentrations. This
is consistent with our previous observation that adrenal
glands from female mice contain smaller amounts of
catecholamines than those of males [1].
The MAP response to CPT was similar in Y1+/+ and Y1/
mice, despite the achievement of higher plasma catechola-
mine concentrations in the latter. This heightened catecho-
lamine discharge observed in Y1/ animals may represent a
compensatory mechanism to maintain normal hemody-
namics in the absence of the Y1 receptor.
The effects of the deletion of the Y1 receptor on HR are
complex. The only consistent finding was that Y1/ females
had a less pronounced reflex bradycardia at the end of the CPT.
In the absence of Y1 receptors, NPY released by sympathetic
nerve terminals and the adrenal medulla can still stimulate
presynaptic Y2 receptors, decreasing thereby the release of NE
by sympathetic nerve terminals, as well as the release of
acetylcholine by parasympathetic nerve terminals. The fact
that Y1 receptor deficient mice exhibited a less pronounced
heart rate decrease at the end of the CPT, comparedwith Y1+/+
animals, suggests a predominant contribution of the para-
sympathetic system in this response.
In conclusion, Y1/ mice maintain a normal blood
pressure response to activation of the sympathetic nerve
Fig. 2 – (A) Mean arterial blood pressure (MAP) and (B) heart rate (HR) response of Y1S/S mice and wild-type mice (Y1+/+),
before (Basal, b) during (1, 2, 3, 4, 5 min) and at the end (15 min) of CPT. *p < 0.05 and **p < 0.01 compared to Y1+/+,
#p < 0.05
and ##p < 0.01 compared to females; yp < 0.05 compared to respective baseline (b); meanW S.D.; n = 7–8.
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discharge in the absence of Y1 receptors.
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